This infographic was supported by Accord Healthcare.
Androgen deprivation therapy (ADT) is essential in advanced prostate cancer but often requires complex, multi-step preparations. CAMCEVI® (leuprolide mesylate) 42 mg Injectable Emulsion is supplied as a prefilled, ready-to-use syringe, no mixing required.
Topics to discover:
- Key trial updates
- Evolution of device design
- Directions for storage and usage
